Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity.

Myles Brown, Tara Akhshi, Shengen Shawn Hu, Esme Wheeler, Christian Hellriegel, Douglas S Richardson, Nicole Cayting, Wangu Mvula, Buraq Ahmed, Rinath Jeselsohn, Chongzhi Zang
{"title":"Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity.","authors":"Myles Brown, Tara Akhshi, Shengen Shawn Hu, Esme Wheeler, Christian Hellriegel, Douglas S Richardson, Nicole Cayting, Wangu Mvula, Buraq Ahmed, Rinath Jeselsohn, Chongzhi Zang","doi":"10.21203/rs.3.rs-6804567/v1","DOIUrl":null,"url":null,"abstract":"<p><p>Changes in gene expression regulated by ligand-dependent transcription factors such as estrogen receptor-α (ERα) involves the recruitment of coactivators including p300 that acetylates histone H3 at lysine 27 (H3K27ac). While H3K27ac marks active enhancers, the detailed chromatin architecture of enhancers remains unclear. Using super-resolution microscopy, we reveal distinct structural states of H3K27ac modified chromatin in response to ERα activation. In estradiol (E2)-treated cells, H3K27ac modified chromatin adopts open, elongated structures associated with active enhancers, while ERα inhibition induces compact, spherical H3K27ac modified chromatin conformations linked to repression. A constitutively active ERα mutation linked to endocrine therapy resistance in breast cancer maintains open chromatin states independent of ligand, suggesting sustained transcriptional activity. Our findings provide the first direct visualization of H3K27ac associated chromatin structural dynamics, challenging the assumption that H3K27ac modification alone is sufficient to lead to enhancer activation. By demonstrating that H3K27ac architecture is dynamically regulated by ERα, we establish a new paradigm for understanding epigenetic regulation and highlight potential therapeutic targets for endocrine therapy resistant cancers.</p>","PeriodicalId":519972,"journal":{"name":"Research square","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204369/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research square","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21203/rs.3.rs-6804567/v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Changes in gene expression regulated by ligand-dependent transcription factors such as estrogen receptor-α (ERα) involves the recruitment of coactivators including p300 that acetylates histone H3 at lysine 27 (H3K27ac). While H3K27ac marks active enhancers, the detailed chromatin architecture of enhancers remains unclear. Using super-resolution microscopy, we reveal distinct structural states of H3K27ac modified chromatin in response to ERα activation. In estradiol (E2)-treated cells, H3K27ac modified chromatin adopts open, elongated structures associated with active enhancers, while ERα inhibition induces compact, spherical H3K27ac modified chromatin conformations linked to repression. A constitutively active ERα mutation linked to endocrine therapy resistance in breast cancer maintains open chromatin states independent of ligand, suggesting sustained transcriptional activity. Our findings provide the first direct visualization of H3K27ac associated chromatin structural dynamics, challenging the assumption that H3K27ac modification alone is sufficient to lead to enhancer activation. By demonstrating that H3K27ac architecture is dynamically regulated by ERα, we establish a new paradigm for understanding epigenetic regulation and highlight potential therapeutic targets for endocrine therapy resistant cancers.

超分辨率显微镜显示雌激素受体活性调节的不同表观遗传状态。
由配体依赖性转录因子如雌激素受体-α (ERα)调控的基因表达变化涉及包括p300在内的共激活因子的募集,p300使组蛋白H3在赖氨酸27位点(H3K27ac)乙酰化。虽然H3K27ac标记了活性增强子,但增强子的详细染色质结构尚不清楚。利用超分辨率显微镜,我们揭示了H3K27ac修饰的染色质在ERα激活下的不同结构状态。在雌二醇(E2)处理的细胞中,H3K27ac修饰的染色质采用开放的、细长的结构,与活性增强子相关,而ERα抑制诱导紧凑的、球形的H3K27ac修饰的染色质构象与抑制相关。与乳腺癌内分泌治疗耐药相关的组成型活性ERα突变维持开放的染色质状态,独立于配体,表明持续的转录活性。我们的发现首次提供了H3K27ac相关染色质结构动力学的直接可视化,挑战了H3K27ac修饰本身足以导致增强子激活的假设。通过证明H3K27ac结构受ERα的动态调控,我们为理解表观遗传调控建立了新的范式,并强调了内分泌治疗耐药癌症的潜在治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信